The @-week randomized double-blind placebo-controlled study compared vildagliptin @mg , q.d. , with placebo as add-on to glimepiride in T@DM patients who were inadequately controlled ( HbA@c @ % -@ % -LSB- @-@mmol / mol -RSB- ) on a stable dose of sulfonylurea for @ weeks before study entry .